PDT Partners’s Keros Therapeutics KROS Stock Holding History

PDT Partners’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.44M	Buy
2025 Q1	$2.81M	Buy
2023 Q2	–	Sell
2023 Q1	$967K	Buy
2022 Q4	$1.09M	Sell
2022 Q3	$853K	Sell
2022 Q2	$1.31M	Buy
2022 Q1	$933K	Buy
2021 Q2	–	Sell
2021 Q1	$239K	Buy